Backbone dynamics of the human MIA protein studied by 15N NMR relaxation: Implications for extended interactions of SH3 domains

Protein Science

Volumn 12, Issue 3, 2003, Pages 510-519

  Stoll, Raphael ^a,e   Renner, Christian ^a   Buettner, Reinhard ^b   Voelter, Wolfgang ^c   Bosserhoff, Anja Katrin ^d   Holak, Tad A ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Backbone dynamics; Binding to SH3 domains

Indexed keywords

MELANOMA INHIBITORY ACTIVITY PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BETA SHEET; HUMAN; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS; TRANSPORT KINETICS;

AMINO ACID SEQUENCE; BINDING SITES; CELL ADHESION; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MELANOMA; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEIN BIOSYNTHESIS; PROTEIN CONFORMATION; PROTEIN FOLDING; SEQUENCE HOMOLOGY, AMINO ACID; SRC HOMOLOGY DOMAINS; TUMOR CELLS, CULTURED;

EID: 0037372353     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.0222603     Document Type: Article

References (46)

1. Albini, A., Iwamoto, Y., Kleinmann, H.K., Martin, G.R., Aaronson, S.A., Kozlowski, J.M., and McEwan, R.N. 1987. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47: 3239-3245.
2. Appel, R.D., Bairoch, A., and Hochstrasser, D.F. 1994. A new generation of information retrieval tools for biologists: The example of the ExPASy WWW server. Trends Biochem. Sci. 19: 258-260.
3. Barnett, P., Bottger, G., Klein, A.T.J., Tabak, H.F., and Distel, B. 2000. The peroxisomal membrane protein Pex13p show a novel mode of SH3 interaction. EMBO J. 19: 6382-6391.
4. Blesch, A., Bosserhoff, A.K., Apfel, R., Behl, C., Hessdoerfer, B., Schmitt, A., Jachimczak, P., Lottspeich, F., Buettner, R., and Bogdahn, U. 1994. Cloning of a novel malignant melanoma-derived growth regulatory protein, MIA. Cancer Res. 54: 5695-5701.
5. Bogdahn, U., Apfel, R., Hahn, M., Gerlach, M., Behl, C., Hoppe, J., and Martin, R. 1989. Autocrine tumor cell growth inhibiting activities from human malignant melanoma. Cancer Res. 49: 5358-5363.
6. Bosserhoff, A.K. and Buettner, R. 2002. Expression, function and clinical relevance of MIA (melanoma inhibitory activity). Histol. Histopathol. 17: 289-300.
7. Bosserhoff, A.K., Kaufmann, M., Kaluza, B., Bartke, I., Zimgibl, H., Hein, R., Stolz, W., and Buettner, R. 1997. MIA, a novel serum marker for progression of malignant melanoma. Cancer Res. 57: 3149-3153.
8. Bosserhoff, A.K., Golob, M., Buettner, R., Landthaler, M., and Hein, R. 1998. MIA (melanoma inhibitory activity) biological functions and clinical relevance. Hautarzt 49: 762-769.
9. Bosserhoff, A.K., Golob., M., Hein, R., and Buettner, R. 1999. Analysis of cell signalling by MIA in active detachment of melanoma cells. J. Invest. Dermatol. 113: 74.
10. Cohen-Salmon, M., Frenz, D., Liu, W., Verpy, E., Voegeling, S., and Petit, C. 2000. Fdp, a new fibrocyte-derived protein related to MIA/CD-RAP, has an in vitro effect on the early differentiation of the inner ear mesenchyme. J. Biol. Chem. 275: 40036-40041.
11. Dalgarno, D.C., Botfield, M.C., and Rickles, R.J. 1997. SH3 domains and drug design: Ligands, structure, and biological function. Biopolymers 43: 383-400.
12. Deichmann, M., Benner, A., Bock, M., Jackel, A., Uhl, K., Waldmann, V., and Naher, H. 1999. S100-β, melanoma inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American joint committee on cancer stage IV melanoma. J. Clin. Onc. Res. 17: 1891-1896.
13. Dietz, U. and Sandell, L.J. 1996. Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis. J. Biol. Chem. 271: 3311-3316.
14. Dosset, P., Hus, J.C., Blackledge, M., and Marion, D. 2000. Efficient analysis of macromolecular rotational diffusion from heteronuclear relaxation data. J. Biomol. NMR. 16: 23-28.
15. Dréau, D., Bosserhoff, A.K., White, R.L., Buettner, R., and Holder, W.D. 1999. Melanoma-inhibitory activity protein, a useful marker to monitor patients treated with immunotherapy. Oncol. Res. 11: 55-61.
16. Edison, A.S., Abildgaard, F., Westler, W.M., Mooberry, E.S., and Markley, J.L. 1994. Practical introduction to theory and implementation of multinuclear, multidimensional nuclear magnetic resonance experiments. Methods Enzymol. 239: 3-79.
17. Falzone, C.J., Kao, Y.H., Zhao, J., Bryant, D.A., and Lecomte, J.T.J. 1994. Three-dimensional solution structure of PsaE from the cyanobacterium Synechococcus sp. Strain PCC 7002, a photosystem I protein that shows structural homology with SH3 domains. Biochemistry 33: 6052-6062.
18. 15N NMR relaxation. Biochemistry 33: 5984-6003.
19. Farrow, N.A., Zhang, O., Forman-Kay, J.D., and Kay, L.E. 1997. Characterization of the backbone dynamics of folded and denatured states of an SH3 domain. Biochemistry 36: 2390-2402.
20. Hansson, H., Mattsson, P.T., Allard, P., Haapaniemi, P., Vihinen, M., Smith, C.I.E., and Härd, T. 1998. Solution structure of the SH3 domain from Bruton's tyrosine kinase. Biochemistry 37: 2912-2924.
21. Jacob, K., Bosserhoff, A.K., Wach, F., Knuchel, R., Klein. E.C., Hein, R., and Buettner, R. 1995. Characterization of selected strongly and weakly invasive sublines of a primary human melanoma cell line and isolation of subtractive cDNA clones. Int. J. Cancer 60: 668-675.
22. Jones, J.A., Hodgkinson, P., Barker, A.L., and Hore, P.J. 1996. Optimal sampling strategies for the measurement of spin-spin relaxation times. J. Magn. Reson. B 113: 25-34.
23. Kang, H., Freund, C., Duke-Cohen, J.S., Musacchio, A., Wagner, G., and Rudd, C.E. 2000. SH3 domain recognition of a proline-independent tyrosine-based RKxxYxxY motif in immune cell adaptor SKAP55. EMBO J. 19: 2889-2899.
24. Kay, L.E. 1998. Protein dynamics from NMR. Bioch. Cell. Biol. 76: 145-152.
25. Klukas, O., Schubert, W.D., Jordan, P., Krauss, N., Fromme, P., Witt, H.T., and Saenger, W. 1999. Photosystem I, an improved model of the stromal subunits PsaC, PsaD, and PsaE. J. Biol. Chem. 274: 7351-7360.
26. Koch, C.A., Anderson, D., Moran, M.F., Ellis, C., and Pawson, T. 1991. SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science 252: 668-674.
27. Koradi, R., Billeter, M., and Wüthrich, K. 1996. MOLMOL: A program for display and analysis of macromolecular structures. J. Mol. Graph. 14: 51-55.
28. Lougheed, J.C., Holton, J.M., Alber, T., Bazan, J.F., and Handel, T.M. 2001. Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins. Proc. Natl. Acad. Sci. 98: 5515-5520.
29. Lougheed, J.C., Domaille, P.J., and Handel, T.M. 2002. Solution structure and dynamics of melanoma inhibitory activity protein. J. Biomol. NMR 22: 211-223.
30. Martínez, J.C., and Serrano, L. 1999. The folding transition state between SH3 domains is conformationally restricted and evolutionarily conserved. Nat. Struc. Biol. 6: 1010-1016.
31. Mayer, K.L., Shen, G., Bryant, D.A., Lecomte, J.T.J., and Falzone, C.J. 1999. The solution structure of photosystem I accessory protein E from the cyanobacterium Nostoc sp. Strain PCC 8009. Biochemistry 38: 13736-13746.
32. Mongiovi, A.M., Romano, P.R., Panni, S., Mendoza, M., Wong, W.T., Musacchio, A., Cesareni, G., and Di Fiore, P.P. 1999. A novel peptide-SH3 interaction. EMBO J. 18: 5300-5309.
33. Müller-Ladner, U., Bosserhoff, A.K., Dreher, K., Hein, R., Neidhart, M., Gay, S., Scholmerich, J., Buettner, R., and Lang, B. 1999. MIA (melanoma inhibitory activity): A potential serum marker for rheumatoid arthritis. Rheumatology 38: 148-154.
34. Musacchio, A., Saraste, M., and Wilmanns M. 1994. High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides. Nat. Struc. Biol. 1: 546-551.
35. Rendtdorff, N.D., Frödin, M., Attié-Bitach, T., Vekemans, M., and Tommerup, N. 2001. Identification and characterization of an inner ear-expressed human melanoma inhibitory activity (MIA)-like gene (MIAL) with a frequent polymorphism that abolishes translation. Genomics 71: 40-52.
36. 1H dipole-dipole relaxation cross-correlation experiments. J. Magn. Reson. 145: 192-200.
37. 15N relaxation of the insulin-like growth factor (IGF)-binding domain if IGF binding protein-5 (IGFBP-5) determined free in solution and in complex with IGF-II. Eur. J. Biochem. 268: 1058-1065.
38. Riddle, D.S., Grantcharova, V.P., Santiago, J.V., Alm, E., Ruczinski, I., and Baker, D. 1999. Experiment and theory highlight role of native state topology in SH3 folding. Nat. Struc. Biol. 6: 1016-1024.
39. Robertson, N.G., Heller, S., Lin, J.S., Resendes, B.L., Weremowicz, S., Denis, C.S., Bell, A.M., Hudspeth, A.J., and Morton, C.C. 2000. A novel conserved cochlear gene, OTOR: Identification, expression analysis, and chromosomal mapping. Genomics 66: 242-248.
40. 15N assignment of the human melanoma inhibitory activity (MIA) protein. J. Biomol. NMR 17: 87-88.
41. Stoll, R., Renner, C., Zweckstetter, M., Bruggert, M., Ambrosius, D., Palme, S., Engh, R.A., Goiob, M., Breibach, I., Buettner, R., et al. 2001. The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold. EMBO J. 20: 340-349.
42. 1H dipolar cross-correlation rates. J. Magn. Reson. 127: 128-133.
43. 15N NMR relaxation. J. Am. Chem. Soc. 117: 12562-12566.
44. Van Groningen, J.J.M., Bloemers, H.P., and Swart, G.W. 1995. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display. Cancer Res. 55: 6237-6243.
45. Yu, H., Rosen, M.K., Shin, T.B., Seidel-Dugan, C., Brugge, J.S., and Schreiber, S.L. 1992. Solution structure of the SH3 domain of Src and identification of its ligand binding site. Science 258: 1665-1668.
46. Yu, H., Chen, J.K., Feng, S., Dalgarno, D.C., Brauer, A.W., and Schreiber, S.L. 1994. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76: 933-945.